Cerebrovascular Pressure Reactivity Has a Strong and Independent Association With Outcome in Children With Severe

Claudia A Smith1,2, Ursula K Rohlwink1,2,3, Katya Mauff4

  • 1Division of Neurosurgery, Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.

Critical Care Medicine
|February 15, 2023
PubMed

Insights

Cerebrovascular pressure reactivity index (PRx) in children with severe traumatic brain injury (sTBI) strongly predicts mortality and poor outcomes. This analysis of PRx in a large pediatric cohort highlights its potential for guiding clinical care.

Area of Science:

  • Pediatric critical care medicine
  • Neurocritical care
  • Cerebrovascular physiology

Background:

  • Severe traumatic brain injury (sTBI) in children presents complex management challenges.
  • Assessing cerebrovascular pressure reactivity is crucial for understanding brain injury pathophysiology.
  • The pressure reactivity index (PRx) offers a quantitative measure of cerebrovascular autoregulation.

Purpose of the Study:

  • To investigate the cerebrovascular pressure reactivity index (PRx) in a large cohort of pediatric patients with sTBI.
  • To determine the association between PRx and physiological variables, mortality, and patient outcomes.
  • To evaluate PRx as a prognostic tool in pediatric sTBI.

Main Methods:

  • Retrospective observational cohort study of pediatric sTBI patients (≤14 years) with intracranial pressure (ICP) monitoring.
  • Calculation of PRx as a moving correlation coefficient between ICP and mean arterial pressure (MAP) using high-frequency data.
  • Statistical analysis including correlation, multivariable logistic regression, and ROC curves to assess PRx associations with outcomes.

Main Results:

  • The study analyzed over 1.7 million minutes of data from 196 children, with a mortality rate of 10.7%.
  • PRx showed moderate positive correlation with ICP and moderate negative correlation with cerebral perfusion pressure (CPP).
  • PRx was significantly higher in patients with poor outcomes and demonstrated a strong, independent association with mortality (ROC AUC = 0.91), with a threshold of 0.25 being optimal for predicting mortality.

Conclusions:

  • This is the largest pediatric cohort study analyzing PRx to date.
  • PRx is a strong, independent predictor of outcome in pediatric sTBI, irrespective of ICP, CPP, GCS, and age.
  • Impaired autoregulation, as indicated by PRx, is a significant factor in poor outcomes and may inform clinical management strategies.
Abstract

Related Concept Videos